Using a qualitative sub-study to inform the design and delivery of randomised controlled trials on medicinal cannabis for symptom relief in patients with advanced cancer

Peer Review reports

Original Submission
4 Apr 2022	Submitted	Original manuscript
29 May 2022	Reviewed	Reviewer Report - Carmel Conefrey
5 Aug 2022	Reviewed	Reviewer Report - Tasmin Rookes
20 Aug 2022	Author responded	Author comments - Rebecca Eileen Olson
Resubmission - Version 2
20 Aug 2022	Submitted	Manuscript version 2
Publishing
24 Aug 2022	Editorially accepted
5 Sep 2022	Article published	10.1186/s13063-022-06691-1

Back to article page